Table of Content

1 Cell Therapy Regenerative Medicine Market Overview
1.1 Product Overview and Scope of Cell Therapy Regenerative Medicine
1.2 Cell Therapy Regenerative Medicine Segment by Type
1.2.1 Global Cell Therapy Regenerative Medicine Market Value Comparison by Type (2023-2033)
1.2.2 NK Cell Therapy
1.2.3 CAR-T Cell Therapy
1.2.4 Others
1.3 Cell Therapy Regenerative Medicine Segment by Application
1.3.1 Global Cell Therapy Regenerative Medicine Market Value by Application: (2023-2033)
1.3.2 Hospital
1.3.3 Medical Research Center
1.3.4 Others
1.4 Global Cell Therapy Regenerative Medicine Market Size Estimates and Forecasts
1.4.1 Global Cell Therapy Regenerative Medicine Revenue 2018-2033
1.4.2 Global Cell Therapy Regenerative Medicine Sales 2018-2033
1.4.3 Global Cell Therapy Regenerative Medicine Market Average Price (2018-2033)
1.5 Assumptions and Limitations
2 Cell Therapy Regenerative Medicine Market Competition by Manufacturers
2.1 Global Cell Therapy Regenerative Medicine Sales Market Share by Manufacturers (2018-2023)
2.2 Global Cell Therapy Regenerative Medicine Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Cell Therapy Regenerative Medicine Average Price by Manufacturers (2018-2023)
2.4 Global Cell Therapy Regenerative Medicine Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Cell Therapy Regenerative Medicine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Cell Therapy Regenerative Medicine, Product Type & Application
2.7 Cell Therapy Regenerative Medicine Market Competitive Situation and Trends
2.7.1 Cell Therapy Regenerative Medicine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Cell Therapy Regenerative Medicine Players Market Share by Revenue
2.7.3 Global Cell Therapy Regenerative Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Cell Therapy Regenerative Medicine Retrospective Market Scenario by Region
3.1 Global Cell Therapy Regenerative Medicine Market Size by Region: 2018 Versus 2022 Versus 2033
3.2 Global Cell Therapy Regenerative Medicine Global Cell Therapy Regenerative Medicine Sales by Region: 2018-2033
3.2.1 Global Cell Therapy Regenerative Medicine Sales by Region: 2018-2023
3.2.2 Global Cell Therapy Regenerative Medicine Sales by Region: 2024-2033
3.3 Global Cell Therapy Regenerative Medicine Global Cell Therapy Regenerative Medicine Revenue by Region: 2018-2033
3.3.1 Global Cell Therapy Regenerative Medicine Revenue by Region: 2018-2023
3.3.2 Global Cell Therapy Regenerative Medicine Revenue by Region: 2024-2033
3.4 North America Cell Therapy Regenerative Medicine Market Facts & Figures by Country
3.4.1 North America Cell Therapy Regenerative Medicine Market Size by Country: 2018 VS 2022 VS 2033
3.4.2 North America Cell Therapy Regenerative Medicine Sales by Country (2018-2033)
3.4.3 North America Cell Therapy Regenerative Medicine Revenue by Country (2018-2033)
3.4.4 United States
3.4.5 Canada
3.5 Europe Cell Therapy Regenerative Medicine Market Facts & Figures by Country
3.5.1 Europe Cell Therapy Regenerative Medicine Market Size by Country: 2018 VS 2022 VS 2033
3.5.2 Europe Cell Therapy Regenerative Medicine Sales by Country (2018-2033)
3.5.3 Europe Cell Therapy Regenerative Medicine Revenue by Country (2018-2033)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Cell Therapy Regenerative Medicine Market Facts & Figures by Country
3.6.1 Asia Pacific Cell Therapy Regenerative Medicine Market Size by Country: 2018 VS 2022 VS 2033
3.6.2 Asia Pacific Cell Therapy Regenerative Medicine Sales by Country (2018-2033)
3.6.3 Asia Pacific Cell Therapy Regenerative Medicine Revenue by Country (2018-2033)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Cell Therapy Regenerative Medicine Market Facts & Figures by Country
3.7.1 Latin America Cell Therapy Regenerative Medicine Market Size by Country: 2018 VS 2022 VS 2033
3.7.2 Latin America Cell Therapy Regenerative Medicine Sales by Country (2018-2033)
3.7.3 Latin America Cell Therapy Regenerative Medicine Revenue by Country (2018-2033)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Cell Therapy Regenerative Medicine Market Facts & Figures by Country
3.8.1 Middle East and Africa Cell Therapy Regenerative Medicine Market Size by Country: 2018 VS 2022 VS 2033
3.8.2 Middle East and Africa Cell Therapy Regenerative Medicine Sales by Country (2018-2033)
3.8.3 Middle East and Africa Cell Therapy Regenerative Medicine Revenue by Country (2018-2033)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Cell Therapy Regenerative Medicine Sales by Type (2018-2033)
4.1.1 Global Cell Therapy Regenerative Medicine Sales by Type (2018-2023)
4.1.2 Global Cell Therapy Regenerative Medicine Sales by Type (2024-2033)
4.1.3 Global Cell Therapy Regenerative Medicine Sales Market Share by Type (2018-2033)
4.2 Global Cell Therapy Regenerative Medicine Revenue by Type (2018-2033)
4.2.1 Global Cell Therapy Regenerative Medicine Revenue by Type (2018-2023)
4.2.2 Global Cell Therapy Regenerative Medicine Revenue by Type (2024-2033)
4.2.3 Global Cell Therapy Regenerative Medicine Revenue Market Share by Type (2018-2033)
4.3 Global Cell Therapy Regenerative Medicine Price by Type (2018-2033)
5 Segment by Application
5.1 Global Cell Therapy Regenerative Medicine Sales by Application (2018-2033)
5.1.1 Global Cell Therapy Regenerative Medicine Sales by Application (2018-2023)
5.1.2 Global Cell Therapy Regenerative Medicine Sales by Application (2024-2033)
5.1.3 Global Cell Therapy Regenerative Medicine Sales Market Share by Application (2018-2033)
5.2 Global Cell Therapy Regenerative Medicine Revenue by Application (2018-2033)
5.2.1 Global Cell Therapy Regenerative Medicine Revenue by Application (2018-2023)
5.2.2 Global Cell Therapy Regenerative Medicine Revenue by Application (2024-2033)
5.2.3 Global Cell Therapy Regenerative Medicine Revenue Market Share by Application (2018-2033)
5.3 Global Cell Therapy Regenerative Medicine Price by Application (2018-2033)
6 Key Companies Profiled
6.1 DePuy Synthes
6.1.1 DePuy Synthes Corporation Information
6.1.2 DePuy Synthes Description and Business Overview
6.1.3 DePuy Synthes Cell Therapy Regenerative Medicine Sales, Revenue and Gross Margin (2018-2023)
6.1.4 DePuy Synthes Cell Therapy Regenerative Medicine Product Portfolio
6.1.5 DePuy Synthes Recent Developments/Updates
6.2 Medtronic
6.2.1 Medtronic Corporation Information
6.2.2 Medtronic Description and Business Overview
6.2.3 Medtronic Cell Therapy Regenerative Medicine Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Medtronic Cell Therapy Regenerative Medicine Product Portfolio
6.2.5 Medtronic Recent Developments/Updates
6.3 ZimmerBiomet
6.3.1 ZimmerBiomet Corporation Information
6.3.2 ZimmerBiomet Description and Business Overview
6.3.3 ZimmerBiomet Cell Therapy Regenerative Medicine Sales, Revenue and Gross Margin (2018-2023)
6.3.4 ZimmerBiomet Cell Therapy Regenerative Medicine Product Portfolio
6.3.5 ZimmerBiomet Recent Developments/Updates
6.4 Stryker
6.4.1 Stryker Corporation Information
6.4.2 Stryker Description and Business Overview
6.4.3 Stryker Cell Therapy Regenerative Medicine Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Stryker Cell Therapy Regenerative Medicine Product Portfolio
6.4.5 Stryker Recent Developments/Updates
6.5 Acelity
6.5.1 Acelity Corporation Information
6.5.2 Acelity Description and Business Overview
6.5.3 Acelity Cell Therapy Regenerative Medicine Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Acelity Cell Therapy Regenerative Medicine Product Portfolio
6.5.5 Acelity Recent Developments/Updates
6.6 MiMedx Group
6.6.1 MiMedx Group Corporation Information
6.6.2 MiMedx Group Description and Business Overview
6.6.3 MiMedx Group Cell Therapy Regenerative Medicine Sales, Revenue and Gross Margin (2018-2023)
6.6.4 MiMedx Group Cell Therapy Regenerative Medicine Product Portfolio
6.6.5 MiMedx Group Recent Developments/Updates
6.7 Organogenesis
6.6.1 Organogenesis Corporation Information
6.6.2 Organogenesis Description and Business Overview
6.6.3 Organogenesis Cell Therapy Regenerative Medicine Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Organogenesis Cell Therapy Regenerative Medicine Product Portfolio
6.7.5 Organogenesis Recent Developments/Updates
6.8 UniQure
6.8.1 UniQure Corporation Information
6.8.2 UniQure Description and Business Overview
6.8.3 UniQure Cell Therapy Regenerative Medicine Sales, Revenue and Gross Margin (2018-2023)
6.8.4 UniQure Cell Therapy Regenerative Medicine Product Portfolio
6.8.5 UniQure Recent Developments/Updates
6.9 Cellular Dynamics International
6.9.1 Cellular Dynamics International Corporation Information
6.9.2 Cellular Dynamics International Description and Business Overview
6.9.3 Cellular Dynamics International Cell Therapy Regenerative Medicine Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Cellular Dynamics International Cell Therapy Regenerative Medicine Product Portfolio
6.9.5 Cellular Dynamics International Recent Developments/Updates
6.10 Osiris Therapeutics
6.10.1 Osiris Therapeutics Corporation Information
6.10.2 Osiris Therapeutics Description and Business Overview
6.10.3 Osiris Therapeutics Cell Therapy Regenerative Medicine Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Osiris Therapeutics Cell Therapy Regenerative Medicine Product Portfolio
6.10.5 Osiris Therapeutics Recent Developments/Updates
6.11 Vcanbio
6.11.1 Vcanbio Corporation Information
6.11.2 Vcanbio Cell Therapy Regenerative Medicine Description and Business Overview
6.11.3 Vcanbio Cell Therapy Regenerative Medicine Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Vcanbio Cell Therapy Regenerative Medicine Product Portfolio
6.11.5 Vcanbio Recent Developments/Updates
6.12 Gamida Cell
6.12.1 Gamida Cell Corporation Information
6.12.2 Gamida Cell Cell Therapy Regenerative Medicine Description and Business Overview
6.12.3 Gamida Cell Cell Therapy Regenerative Medicine Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Gamida Cell Cell Therapy Regenerative Medicine Product Portfolio
6.12.5 Gamida Cell Recent Developments/Updates
6.13 Golden Meditech
6.13.1 Golden Meditech Corporation Information
6.13.2 Golden Meditech Cell Therapy Regenerative Medicine Description and Business Overview
6.13.3 Golden Meditech Cell Therapy Regenerative Medicine Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Golden Meditech Cell Therapy Regenerative Medicine Product Portfolio
6.13.5 Golden Meditech Recent Developments/Updates
6.14 Cytori
6.14.1 Cytori Corporation Information
6.14.2 Cytori Cell Therapy Regenerative Medicine Description and Business Overview
6.14.3 Cytori Cell Therapy Regenerative Medicine Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Cytori Cell Therapy Regenerative Medicine Product Portfolio
6.14.5 Cytori Recent Developments/Updates
6.15 Celgene
6.15.1 Celgene Corporation Information
6.15.2 Celgene Cell Therapy Regenerative Medicine Description and Business Overview
6.15.3 Celgene Cell Therapy Regenerative Medicine Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Celgene Cell Therapy Regenerative Medicine Product Portfolio
6.15.5 Celgene Recent Developments/Updates
6.16 Vericel Corporation
6.16.1 Vericel Corporation Corporation Information
6.16.2 Vericel Corporation Cell Therapy Regenerative Medicine Description and Business Overview
6.16.3 Vericel Corporation Cell Therapy Regenerative Medicine Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Vericel Corporation Cell Therapy Regenerative Medicine Product Portfolio
6.16.5 Vericel Corporation Recent Developments/Updates
6.17 Guanhao Biotech
6.17.1 Guanhao Biotech Corporation Information
6.17.2 Guanhao Biotech Cell Therapy Regenerative Medicine Description and Business Overview
6.17.3 Guanhao Biotech Cell Therapy Regenerative Medicine Sales, Revenue and Gross Margin (2018-2023)
6.17.4 Guanhao Biotech Cell Therapy Regenerative Medicine Product Portfolio
6.17.5 Guanhao Biotech Recent Developments/Updates
6.18 Mesoblast
6.18.1 Mesoblast Corporation Information
6.18.2 Mesoblast Cell Therapy Regenerative Medicine Description and Business Overview
6.18.3 Mesoblast Cell Therapy Regenerative Medicine Sales, Revenue and Gross Margin (2018-2023)
6.18.4 Mesoblast Cell Therapy Regenerative Medicine Product Portfolio
6.18.5 Mesoblast Recent Developments/Updates
6.19 Stemcell Technologies
6.19.1 Stemcell Technologies Corporation Information
6.19.2 Stemcell Technologies Cell Therapy Regenerative Medicine Description and Business Overview
6.19.3 Stemcell Technologies Cell Therapy Regenerative Medicine Sales, Revenue and Gross Margin (2018-2023)
6.19.4 Stemcell Technologies Cell Therapy Regenerative Medicine Product Portfolio
6.19.5 Stemcell Technologies Recent Developments/Updates
6.20 Bellicum Pharmaceuticals
6.20.1 Bellicum Pharmaceuticals Corporation Information
6.20.2 Bellicum Pharmaceuticals Cell Therapy Regenerative Medicine Description and Business Overview
6.20.3 Bellicum Pharmaceuticals Cell Therapy Regenerative Medicine Sales, Revenue and Gross Margin (2018-2023)
6.20.4 Bellicum Pharmaceuticals Cell Therapy Regenerative Medicine Product Portfolio
6.20.5 Bellicum Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Cell Therapy Regenerative Medicine Industry Chain Analysis
7.2 Cell Therapy Regenerative Medicine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Cell Therapy Regenerative Medicine Production Mode & Process
7.4 Cell Therapy Regenerative Medicine Sales and Marketing
7.4.1 Cell Therapy Regenerative Medicine Sales Channels
7.4.2 Cell Therapy Regenerative Medicine Distributors
7.5 Cell Therapy Regenerative Medicine Customers
8 Cell Therapy Regenerative Medicine Market Dynamics
8.1 Cell Therapy Regenerative Medicine Industry Trends
8.2 Cell Therapy Regenerative Medicine Market Drivers
8.3 Cell Therapy Regenerative Medicine Market Challenges
8.4 Cell Therapy Regenerative Medicine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Cell Therapy Regenerative Medicine Market Value Comparison by Type (2023-2033) & (US$ Million)
Table 2. Global Cell Therapy Regenerative Medicine Market Value Comparison by Application (2023-2033) & (US$ Million)
Table 3. Global Cell Therapy Regenerative Medicine Market Competitive Situation by Manufacturers in 2022
Table 4. Global Cell Therapy Regenerative Medicine Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Cell Therapy Regenerative Medicine Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Cell Therapy Regenerative Medicine Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Cell Therapy Regenerative Medicine Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Cell Therapy Regenerative Medicine Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Cell Therapy Regenerative Medicine, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Cell Therapy Regenerative Medicine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Cell Therapy Regenerative Medicine, Product Type & Application
Table 12. Global Key Manufacturers of Cell Therapy Regenerative Medicine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Cell Therapy Regenerative Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell Therapy Regenerative Medicine as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Cell Therapy Regenerative Medicine Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 17. Global Cell Therapy Regenerative Medicine Sales by Region (2018-2023) & (K Units)
Table 18. Global Cell Therapy Regenerative Medicine Sales Market Share by Region (2018-2023)
Table 19. Global Cell Therapy Regenerative Medicine Sales by Region (2024-2033) & (K Units)
Table 20. Global Cell Therapy Regenerative Medicine Sales Market Share by Region (2024-2033)
Table 21. Global Cell Therapy Regenerative Medicine Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Cell Therapy Regenerative Medicine Revenue Market Share by Region (2018-2023)
Table 23. Global Cell Therapy Regenerative Medicine Revenue by Region (2024-2033) & (US$ Million)
Table 24. Global Cell Therapy Regenerative Medicine Revenue Market Share by Region (2024-2033)
Table 25. North America Cell Therapy Regenerative Medicine Revenue by Country: 2018 VS 2022 VS 2033 (US$ Million)
Table 26. North America Cell Therapy Regenerative Medicine Sales by Country (2018-2023) & (K Units)
Table 27. North America Cell Therapy Regenerative Medicine Sales by Country (2024-2033) & (K Units)
Table 28. North America Cell Therapy Regenerative Medicine Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Cell Therapy Regenerative Medicine Revenue by Country (2024-2033) & (US$ Million)
Table 30. Europe Cell Therapy Regenerative Medicine Revenue by Country: 2018 VS 2022 VS 2033 (US$ Million)
Table 31. Europe Cell Therapy Regenerative Medicine Sales by Country (2018-2023) & (K Units)
Table 32. Europe Cell Therapy Regenerative Medicine Sales by Country (2024-2033) & (K Units)
Table 33. Europe Cell Therapy Regenerative Medicine Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Cell Therapy Regenerative Medicine Revenue by Country (2024-2033) & (US$ Million)
Table 35. Asia Pacific Cell Therapy Regenerative Medicine Revenue by Region: 2018 VS 2022 VS 2033 (US$ Million)
Table 36. Asia Pacific Cell Therapy Regenerative Medicine Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Cell Therapy Regenerative Medicine Sales by Region (2024-2033) & (K Units)
Table 38. Asia Pacific Cell Therapy Regenerative Medicine Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Cell Therapy Regenerative Medicine Revenue by Region (2024-2033) & (US$ Million)
Table 40. Latin America Cell Therapy Regenerative Medicine Revenue by Country: 2018 VS 2022 VS 2033 (US$ Million)
Table 41. Latin America Cell Therapy Regenerative Medicine Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Cell Therapy Regenerative Medicine Sales by Country (2024-2033) & (K Units)
Table 43. Latin America Cell Therapy Regenerative Medicine Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Cell Therapy Regenerative Medicine Revenue by Country (2024-2033) & (US$ Million)
Table 45. Middle East & Africa Cell Therapy Regenerative Medicine Revenue by Country: 2018 VS 2022 VS 2033 (US$ Million)
Table 46. Middle East & Africa Cell Therapy Regenerative Medicine Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Cell Therapy Regenerative Medicine Sales by Country (2024-2033) & (K Units)
Table 48. Middle East & Africa Cell Therapy Regenerative Medicine Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Cell Therapy Regenerative Medicine Revenue by Country (2024-2033) & (US$ Million)
Table 50. Global Cell Therapy Regenerative Medicine Sales (K Units) by Type (2018-2023)
Table 51. Global Cell Therapy Regenerative Medicine Sales (K Units) by Type (2024-2033)
Table 52. Global Cell Therapy Regenerative Medicine Sales Market Share by Type (2018-2023)
Table 53. Global Cell Therapy Regenerative Medicine Sales Market Share by Type (2024-2033)
Table 54. Global Cell Therapy Regenerative Medicine Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Cell Therapy Regenerative Medicine Revenue (US$ Million) by Type (2024-2033)
Table 56. Global Cell Therapy Regenerative Medicine Revenue Market Share by Type (2018-2023)
Table 57. Global Cell Therapy Regenerative Medicine Revenue Market Share by Type (2024-2033)
Table 58. Global Cell Therapy Regenerative Medicine Price (US$/Unit) by Type (2018-2023)
Table 59. Global Cell Therapy Regenerative Medicine Price (US$/Unit) by Type (2024-2033)
Table 60. Global Cell Therapy Regenerative Medicine Sales (K Units) by Application (2018-2023)
Table 61. Global Cell Therapy Regenerative Medicine Sales (K Units) by Application (2024-2033)
Table 62. Global Cell Therapy Regenerative Medicine Sales Market Share by Application (2018-2023)
Table 63. Global Cell Therapy Regenerative Medicine Sales Market Share by Application (2024-2033)
Table 64. Global Cell Therapy Regenerative Medicine Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Cell Therapy Regenerative Medicine Revenue (US$ Million) by Application (2024-2033)
Table 66. Global Cell Therapy Regenerative Medicine Revenue Market Share by Application (2018-2023)
Table 67. Global Cell Therapy Regenerative Medicine Revenue Market Share by Application (2024-2033)
Table 68. Global Cell Therapy Regenerative Medicine Price (US$/Unit) by Application (2018-2023)
Table 69. Global Cell Therapy Regenerative Medicine Price (US$/Unit) by Application (2024-2033)
Table 70. DePuy Synthes Corporation Information
Table 71. DePuy Synthes Description and Business Overview
Table 72. DePuy Synthes Cell Therapy Regenerative Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. DePuy Synthes Cell Therapy Regenerative Medicine Product
Table 74. DePuy Synthes Recent Developments/Updates
Table 75. Medtronic Corporation Information
Table 76. Medtronic Description and Business Overview
Table 77. Medtronic Cell Therapy Regenerative Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. Medtronic Cell Therapy Regenerative Medicine Product
Table 79. Medtronic Recent Developments/Updates
Table 80. ZimmerBiomet Corporation Information
Table 81. ZimmerBiomet Description and Business Overview
Table 82. ZimmerBiomet Cell Therapy Regenerative Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. ZimmerBiomet Cell Therapy Regenerative Medicine Product
Table 84. ZimmerBiomet Recent Developments/Updates
Table 85. Stryker Corporation Information
Table 86. Stryker Description and Business Overview
Table 87. Stryker Cell Therapy Regenerative Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Stryker Cell Therapy Regenerative Medicine Product
Table 89. Stryker Recent Developments/Updates
Table 90. Acelity Corporation Information
Table 91. Acelity Description and Business Overview
Table 92. Acelity Cell Therapy Regenerative Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Acelity Cell Therapy Regenerative Medicine Product
Table 94. Acelity Recent Developments/Updates
Table 95. MiMedx Group Corporation Information
Table 96. MiMedx Group Description and Business Overview
Table 97. MiMedx Group Cell Therapy Regenerative Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. MiMedx Group Cell Therapy Regenerative Medicine Product
Table 99. MiMedx Group Recent Developments/Updates
Table 100. Organogenesis Corporation Information
Table 101. Organogenesis Description and Business Overview
Table 102. Organogenesis Cell Therapy Regenerative Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Organogenesis Cell Therapy Regenerative Medicine Product
Table 104. Organogenesis Recent Developments/Updates
Table 105. UniQure Corporation Information
Table 106. UniQure Description and Business Overview
Table 107. UniQure Cell Therapy Regenerative Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. UniQure Cell Therapy Regenerative Medicine Product
Table 109. UniQure Recent Developments/Updates
Table 110. Cellular Dynamics International Corporation Information
Table 111. Cellular Dynamics International Description and Business Overview
Table 112. Cellular Dynamics International Cell Therapy Regenerative Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Cellular Dynamics International Cell Therapy Regenerative Medicine Product
Table 114. Cellular Dynamics International Recent Developments/Updates
Table 115. Osiris Therapeutics Corporation Information
Table 116. Osiris Therapeutics Description and Business Overview
Table 117. Osiris Therapeutics Cell Therapy Regenerative Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Osiris Therapeutics Cell Therapy Regenerative Medicine Product
Table 119. Osiris Therapeutics Recent Developments/Updates
Table 120. Vcanbio Corporation Information
Table 121. Vcanbio Description and Business Overview
Table 122. Vcanbio Cell Therapy Regenerative Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. Vcanbio Cell Therapy Regenerative Medicine Product
Table 124. Vcanbio Recent Developments/Updates
Table 125. Gamida Cell Corporation Information
Table 126. Gamida Cell Description and Business Overview
Table 127. Gamida Cell Cell Therapy Regenerative Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. Gamida Cell Cell Therapy Regenerative Medicine Product
Table 129. Gamida Cell Recent Developments/Updates
Table 130. Golden Meditech Corporation Information
Table 131. Golden Meditech Description and Business Overview
Table 132. Golden Meditech Cell Therapy Regenerative Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 133. Golden Meditech Cell Therapy Regenerative Medicine Product
Table 134. Golden Meditech Recent Developments/Updates
Table 135. Cytori Corporation Information
Table 136. Cytori Description and Business Overview
Table 137. Cytori Cell Therapy Regenerative Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 138. Cytori Cell Therapy Regenerative Medicine Product
Table 139. Cytori Recent Developments/Updates
Table 140. Celgene Corporation Information
Table 141. Celgene Description and Business Overview
Table 142. Celgene Cell Therapy Regenerative Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 143. Celgene Cell Therapy Regenerative Medicine Product
Table 144. Celgene Recent Developments/Updates
Table 145. Vericel Corporation Corporation Information
Table 146. Vericel Corporation Description and Business Overview
Table 147. Vericel Corporation Cell Therapy Regenerative Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 148. Vericel Corporation Cell Therapy Regenerative Medicine Product
Table 149. Vericel Corporation Recent Developments/Updates
Table 150. Guanhao Biotech Corporation Information
Table 151. Guanhao Biotech Description and Business Overview
Table 152. Guanhao Biotech Cell Therapy Regenerative Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 153. Guanhao Biotech Cell Therapy Regenerative Medicine Product
Table 154. Guanhao Biotech Recent Developments/Updates
Table 155. Mesoblast Corporation Information
Table 156. Mesoblast Description and Business Overview
Table 157. Mesoblast Cell Therapy Regenerative Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 158. Mesoblast Cell Therapy Regenerative Medicine Product
Table 159. Mesoblast Recent Developments/Updates
Table 160. Stemcell Technologies Corporation Information
Table 161. Stemcell Technologies Description and Business Overview
Table 162. Stemcell Technologies Cell Therapy Regenerative Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 163. Stemcell Technologies Cell Therapy Regenerative Medicine Product
Table 164. Stemcell Technologies Recent Developments/Updates
Table 165. Bellicum Pharmaceuticals Corporation Information
Table 166. Bellicum Pharmaceuticals Description and Business Overview
Table 167. Bellicum Pharmaceuticals Cell Therapy Regenerative Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 168. Bellicum Pharmaceuticals Cell Therapy Regenerative Medicine Product
Table 169. Bellicum Pharmaceuticals Recent Developments/Updates
Table 170. Key Raw Materials Lists
Table 171. Raw Materials Key Suppliers Lists
Table 172. Cell Therapy Regenerative Medicine Distributors List
Table 173. Cell Therapy Regenerative Medicine Customers List
Table 174. Cell Therapy Regenerative Medicine Market Trends
Table 175. Cell Therapy Regenerative Medicine Market Drivers
Table 176. Cell Therapy Regenerative Medicine Market Challenges
Table 177. Cell Therapy Regenerative Medicine Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Cell Therapy Regenerative Medicine
Figure 2. Global Cell Therapy Regenerative Medicine Market Value Comparison by Type (2023-2033) & (US$ Million)
Figure 3. Global Cell Therapy Regenerative Medicine Market Share by Type in 2022 & 2033
Figure 4. NK Cell Therapy Product Picture
Figure 5. CAR-T Cell Therapy Product Picture
Figure 6. Others Product Picture
Figure 7. Global Cell Therapy Regenerative Medicine Market Value Comparison by Application (2023-2033) & (US$ Million)
Figure 8. Global Cell Therapy Regenerative Medicine Market Share by Application in 2022 & 2033
Figure 9. Hospital
Figure 10. Medical Research Center
Figure 11. Others
Figure 12. Global Cell Therapy Regenerative Medicine Revenue, (US$ Million), 2018 VS 2022 VS 2033
Figure 13. Global Cell Therapy Regenerative Medicine Market Size (2018-2033) & (US$ Million)
Figure 14. Global Cell Therapy Regenerative Medicine Sales (2018-2033) & (K Units)
Figure 15. Global Cell Therapy Regenerative Medicine Average Price (US$/Unit) & (2018-2033)
Figure 16. Cell Therapy Regenerative Medicine Report Years Considered
Figure 17. Cell Therapy Regenerative Medicine Sales Share by Manufacturers in 2022
Figure 18. Global Cell Therapy Regenerative Medicine Revenue Share by Manufacturers in 2022
Figure 19. The Global 5 and 10 Largest Cell Therapy Regenerative Medicine Players: Market Share by Revenue in 2022
Figure 20. Cell Therapy Regenerative Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 21. Global Cell Therapy Regenerative Medicine Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Figure 22. North America Cell Therapy Regenerative Medicine Sales Market Share by Country (2018-2033)
Figure 23. North America Cell Therapy Regenerative Medicine Revenue Market Share by Country (2018-2033)
Figure 24. United States Cell Therapy Regenerative Medicine Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 25. Canada Cell Therapy Regenerative Medicine Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 26. Europe Cell Therapy Regenerative Medicine Sales Market Share by Country (2018-2033)
Figure 27. Europe Cell Therapy Regenerative Medicine Revenue Market Share by Country (2018-2033)
Figure 28. Germany Cell Therapy Regenerative Medicine Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 29. France Cell Therapy Regenerative Medicine Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 30. U.K. Cell Therapy Regenerative Medicine Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 31. Italy Cell Therapy Regenerative Medicine Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 32. Russia Cell Therapy Regenerative Medicine Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 33. Asia Pacific Cell Therapy Regenerative Medicine Sales Market Share by Region (2018-2033)
Figure 34. Asia Pacific Cell Therapy Regenerative Medicine Revenue Market Share by Region (2018-2033)
Figure 35. China Cell Therapy Regenerative Medicine Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 36. Japan Cell Therapy Regenerative Medicine Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 37. South Korea Cell Therapy Regenerative Medicine Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 38. India Cell Therapy Regenerative Medicine Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 39. Australia Cell Therapy Regenerative Medicine Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 40. China Taiwan Cell Therapy Regenerative Medicine Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 41. Indonesia Cell Therapy Regenerative Medicine Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 42. Thailand Cell Therapy Regenerative Medicine Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 43. Malaysia Cell Therapy Regenerative Medicine Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 44. Latin America Cell Therapy Regenerative Medicine Sales Market Share by Country (2018-2033)
Figure 45. Latin America Cell Therapy Regenerative Medicine Revenue Market Share by Country (2018-2033)
Figure 46. Mexico Cell Therapy Regenerative Medicine Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 47. Brazil Cell Therapy Regenerative Medicine Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 48. Argentina Cell Therapy Regenerative Medicine Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 49. Middle East & Africa Cell Therapy Regenerative Medicine Sales Market Share by Country (2018-2033)
Figure 50. Middle East & Africa Cell Therapy Regenerative Medicine Revenue Market Share by Country (2018-2033)
Figure 51. Turkey Cell Therapy Regenerative Medicine Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 52. Saudi Arabia Cell Therapy Regenerative Medicine Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 53. UAE Cell Therapy Regenerative Medicine Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 54. Global Sales Market Share of Cell Therapy Regenerative Medicine by Type (2018-2033)
Figure 55. Global Revenue Market Share of Cell Therapy Regenerative Medicine by Type (2018-2033)
Figure 56. Global Cell Therapy Regenerative Medicine Price (US$/Unit) by Type (2018-2033)
Figure 57. Global Sales Market Share of Cell Therapy Regenerative Medicine by Application (2018-2033)
Figure 58. Global Revenue Market Share of Cell Therapy Regenerative Medicine by Application (2018-2033)
Figure 59. Global Cell Therapy Regenerative Medicine Price (US$/Unit) by Application (2018-2033)
Figure 60. Cell Therapy Regenerative Medicine Value Chain
Figure 61. Cell Therapy Regenerative Medicine Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed